Neogen Corporation Selling and Marketing Expense
Neogen Corporation (NEOG) reported Selling and Marketing Expense of $166.60 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-07-30
- Neogen Corporation selling and marketing expense for the quarter ending 2026-05-31 was $41.10M, a 12.37% decline year-over-year.
- Neogen Corporation selling and marketing expense for the quarter ending 2026-02-28 was $38.20M, a 14.35% decline year-over-year.
- Neogen Corporation selling and marketing expense for the quarter ending 2025-11-30 was $42.29M, a 9.14% decline year-over-year.
- Neogen Corporation selling and marketing expense for the quarter ending 2025-08-31 was $45.05M, a 1.64% decline year-over-year.
- Neogen Corporation selling and marketing expense for fiscal 2026 was $166.60M, a 9.36% decline from fiscal 2025.
- Neogen Corporation selling and marketing expense for fiscal 2025 was $183.80M, a 0.49% increase from fiscal 2024.
- Neogen Corporation selling and marketing expense for fiscal 2024 was $182.90M, a 29.51% increase from fiscal 2023.
- Neogen Corporation selling and marketing expense for fiscal 2023 was $141.22M, a 66.92% increase from fiscal 2022.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $41.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $79.30M derived: sum of 2 quarters · filed 2026-07-30 | $121.59M derived: sum of 3 quarters · filed 2026-07-30 | $166.60M 10-K · filed 2026-07-30 | ||||
| 2026-02-28 | $38.20M 10-Q · filed 2026-04-09 | $80.49M derived: sum of 2 quarters · filed 2026-04-09 | $125.50M 10-Q · filed 2026-04-09 | $172.44M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-11-30 | $42.29M 10-Q · filed 2026-01-08 | $87.34M 10-Q · filed 2026-01-08 | $134.24M derived: sum of 3 quarters · filed 2026-07-30 | $178.84M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-08-31 | $45.05M 10-Q · filed 2025-10-09 | $91.95M derived: sum of 2 quarters · filed 2026-07-30 | $136.55M derived: sum of 3 quarters · filed 2026-07-30 | $183.09M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-05-31 | $46.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $91.50M derived: sum of 2 quarters · filed 2026-07-30 | $138.04M derived: sum of 3 quarters · filed 2026-07-30 | $183.80M 10-K · filed 2026-07-30 | $183.80M 10-K · filed 2025-07-30 | |||
| 2025-02-28 | $44.60M 10-Q · filed 2026-04-09 | $44.59M 10-Q · filed 2025-04-09 | $91.14M derived: sum of 2 quarters · filed 2026-04-09 | $136.90M 10-Q · filed 2026-04-09 | $136.94M 10-Q · filed 2025-04-09 | $181.31M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-11-30 | $46.55M 10-Q · filed 2026-01-08 | $92.34M 10-Q · filed 2026-01-08 | $136.71M derived: sum of 3 quarters · filed 2026-07-30 | $184.63M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2024-08-31 | $45.80M 10-Q · filed 2025-10-09 | $90.16M derived: sum of 2 quarters · filed 2026-07-30 | $138.08M derived: sum of 3 quarters · filed 2026-07-30 | $182.92M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2024-05-31 | $44.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $92.28M derived: sum of 2 quarters · filed 2026-07-30 | $137.12M derived: sum of 3 quarters · filed 2026-07-30 | $182.90M 10-K · filed 2026-07-30 | $182.87M 10-K · filed 2024-07-30 | |||
| 2024-02-29 | $47.92M 10-Q · filed 2025-04-09 | $92.75M derived: sum of 2 quarters · filed 2025-04-09 | $138.53M 10-Q · filed 2025-04-09 | $181.43M derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2023-11-30 | $44.83M 10-Q · filed 2025-01-15 | $90.61M 10-Q · filed 2025-01-15 | $133.51M derived: sum of 3 quarters · filed 2025-07-30 | $172.11M derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2023-08-31 | $45.78M 10-Q · filed 2024-10-10 | $88.68M derived: sum of 2 quarters · filed 2025-07-30 | $127.27M derived: sum of 3 quarters · filed 2025-07-30 | $163.62M derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2023-05-31 | $42.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $81.49M derived: sum of 2 quarters · filed 2025-07-30 | $117.84M derived: sum of 3 quarters · filed 2025-07-30 | $141.22M 10-K · filed 2025-07-30 | ||||
| 2023-02-28 | $38.60M 10-Q · filed 2024-04-09 | $74.95M derived: sum of 2 quarters · filed 2024-04-09 | $98.33M 10-Q · filed 2024-04-09 | $119.71M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-11-30 | $36.35M 10-Q · filed 2024-01-09 | $59.73M 10-Q · filed 2024-01-09 | $81.11M derived: sum of 3 quarters · filed 2024-07-30 | $102.59M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-08-31 | $23.38M 10-Q · filed 2023-10-10 | $44.77M derived: sum of 2 quarters · filed 2024-07-30 | $66.24M derived: sum of 3 quarters · filed 2024-07-30 | $87.43M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-05-31 | $21.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $42.86M derived: sum of 2 quarters · filed 2024-07-30 | $64.05M derived: sum of 3 quarters · filed 2024-07-30 | $84.60M 10-K · filed 2024-07-30 | ||||
| 2022-02-28 | $21.48M 10-Q · filed 2023-04-04 | $42.66M derived: sum of 2 quarters · filed 2023-04-04 | $63.22M 10-Q · filed 2023-04-04 | $83.72M derived: sum of 4 quarters · filed 2023-08-15 | ||||
| 2021-11-30 | $21.19M 10-Q · filed 2023-01-09 | $41.74M 10-Q · filed 2023-01-09 | $62.25M derived: sum of 3 quarters · filed 2023-08-15 | $80.94M derived: sum of 4 quarters · filed 2023-08-15 | ||||
| 2021-08-31 | $20.55M 10-Q · filed 2022-09-30 | $41.06M derived: sum of 2 quarters · filed 2023-08-15 | $59.75M derived: sum of 3 quarters · filed 2023-08-15 | $77.48M derived: sum of 4 quarters · filed 2023-08-15 | ||||
| 2021-05-31 | $20.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $39.20M derived: sum of 2 quarters · filed 2023-08-15 | $56.93M derived: sum of 3 quarters · filed 2023-08-15 | $73.44M 10-K · filed 2023-08-15 | ||||
| 2021-02-28 | $18.69M 10-Q · filed 2022-04-01 | $36.42M derived: sum of 2 quarters · filed 2022-04-01 | $52.94M 10-Q · filed 2022-04-01 | $69.41M derived: sum of 4 quarters · filed 2022-07-27 | ||||
| 2020-11-30 | $17.73M 10-Q · filed 2021-12-30 | $34.24M 10-Q · filed 2021-12-30 | $50.71M derived: sum of 3 quarters · filed 2022-07-27 | $68.39M derived: sum of 4 quarters · filed 2022-07-27 | ||||
| 2020-08-31 | $16.52M 10-Q · filed 2021-09-30 | $32.98M derived: sum of 2 quarters · filed 2022-07-27 | $50.66M derived: sum of 3 quarters · filed 2022-07-27 | $68.65M derived: sum of 4 quarters · filed 2022-07-27 | ||||
| 2020-05-31 | $16.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $34.14M derived: sum of 2 quarters · filed 2022-07-27 | $52.13M derived: sum of 3 quarters · filed 2022-07-27 | $69.67M 10-K · filed 2022-07-27 | ||||
| 2020-02-29 | $17.68M 10-Q · filed 2021-03-31 | $35.66M derived: sum of 2 quarters · filed 2021-03-31 | $53.21M 10-Q · filed 2021-03-31 | $70.98M derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2019-11-30 | $17.99M 10-Q · filed 2020-12-29 | $35.53M 10-Q · filed 2020-12-29 | $53.31M derived: sum of 3 quarters · filed 2021-07-30 | $70.03M derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2019-08-31 | $17.54M 10-Q · filed 2020-09-30 | $35.32M derived: sum of 2 quarters · filed 2021-07-30 | $52.04M derived: sum of 3 quarters · filed 2021-07-30 | $70.54M derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2019-05-31 | $17.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $34.50M derived: sum of 2 quarters · filed 2021-07-30 | $53.00M derived: sum of 3 quarters · filed 2021-07-30 | $70.23M 10-K · filed 2021-07-30 | ||||
| 2019-02-28 | $16.72M 10-Q · filed 2020-04-03 | $35.22M derived: sum of 2 quarters · filed 2020-04-03 | $52.45M 10-Q · filed 2020-04-03 | $69.94M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2018-11-30 | $18.50M 10-Q · filed 2018-12-28 | $35.73M 10-Q · filed 2019-12-27 | $53.22M derived: sum of 3 quarters · filed 2020-07-30 | $69.79M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2018-08-31 | $17.23M 10-Q · filed 2019-09-26 | $34.72M derived: sum of 2 quarters · filed 2020-07-30 | $51.29M derived: sum of 3 quarters · filed 2020-07-30 | $68.05M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2018-05-31 | $17.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $34.06M derived: sum of 2 quarters · filed 2020-07-30 | $50.82M derived: sum of 3 quarters · filed 2020-07-30 | $66.93M 10-K · filed 2020-07-30 | $70.91M 10-K · filed 2018-07-27 | |||
| 2018-02-28 | $16.57M 10-Q · filed 2019-03-29 | $17.49M 10-Q · filed 2018-03-29 | $33.33M derived: sum of 2 quarters · filed 2019-03-29 | $49.44M 10-Q · filed 2019-03-29 | $52.33M 10-Q · filed 2018-03-29 | $62.97M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-11-30 | $16.79M 10-Q · filed 2018-12-28 | $17.82M 10-Q · filed 2018-01-05 | $32.87M 10-Q · filed 2018-12-28 | $34.84M 10-Q · filed 2018-01-05 | $46.40M derived: sum of 3 quarters · filed 2019-07-30 | $61.73M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-08-31 | $16.08M 10-Q · filed 2018-10-05 | $17.02M 10-Q · filed 2017-09-29 | $29.63M derived: sum of 2 quarters · filed 2019-07-30 | $44.97M derived: sum of 3 quarters · filed 2019-07-30 | $60.66M derived: sum of 4 quarters · filed 2019-07-30 | |||
| 2017-05-31 | $13.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | $28.90M derived: sum of 2 quarters · filed 2019-07-30 | $44.58M derived: sum of 3 quarters · filed 2019-07-30 | $59.38M 10-K · filed 2019-07-30 | $62.42M 10-K · filed 2017-07-28 | |||
| 2017-02-28 | $15.34M 10-Q · filed 2018-03-29 | $31.03M derived: sum of 2 quarters · filed 2018-03-29 | $45.82M 10-Q · filed 2018-03-29 | $61.70M derived: sum of 4 quarters · filed 2018-07-27 | ||||
| 2016-11-30 | $15.69M 10-Q · filed 2018-01-05 | $30.48M 10-Q · filed 2018-01-05 | $46.36M derived: sum of 3 quarters · filed 2018-07-27 | $60.31M derived: sum of 4 quarters · filed 2018-07-27 | ||||
| 2016-08-31 | $14.80M 10-Q · filed 2017-09-29 | $30.67M derived: sum of 2 quarters · filed 2018-07-27 | $44.62M derived: sum of 3 quarters · filed 2018-07-27 | $58.83M derived: sum of 4 quarters · filed 2018-07-27 | ||||
| 2016-05-31 | $15.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | $29.82M derived: sum of 2 quarters · filed 2018-07-27 | $44.03M derived: sum of 3 quarters · filed 2018-07-27 | $57.60M 10-K · filed 2018-07-27 | ||||
| 2016-02-29 | $13.95M 10-Q · filed 2017-03-31 | $28.16M derived: sum of 2 quarters · filed 2017-03-31 | $41.73M 10-Q · filed 2017-03-31 | $55.87M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-11-30 | $14.20M 10-Q · filed 2016-12-29 | $27.77M 10-Q · filed 2016-12-29 | $41.91M derived: sum of 3 quarters · filed 2017-07-28 | $54.57M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-08-31 | $13.57M 10-Q · filed 2016-09-30 | $27.71M derived: sum of 2 quarters · filed 2017-07-28 | $40.37M derived: sum of 3 quarters · filed 2017-07-28 | $53.11M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-05-31 | $14.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $26.80M derived: sum of 2 quarters · filed 2017-07-28 | $39.54M derived: sum of 3 quarters · filed 2017-07-28 | $51.76M 10-K · filed 2017-07-28 | ||||
| 2015-02-28 | $12.65M 10-Q · filed 2016-03-31 | $25.40M derived: sum of 2 quarters · filed 2016-03-31 | $37.62M 10-Q · filed 2016-03-31 | $50.52M derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2014-11-30 | $12.74M 10-Q · filed 2016-01-08 | $24.96M 10-Q · filed 2016-01-08 | $37.87M derived: sum of 3 quarters · filed 2016-07-29 | $49.85M derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2014-08-31 | $12.22M 10-Q · filed 2015-09-30 | $25.12M derived: sum of 2 quarters · filed 2016-07-29 | $37.11M derived: sum of 3 quarters · filed 2016-07-29 | $48.33M derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2014-05-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $24.89M derived: sum of 2 quarters · filed 2016-07-29 | $36.11M derived: sum of 3 quarters · filed 2016-07-29 | $46.43M 10-K · filed 2016-07-29 | ||||
| 2014-02-28 | $11.99M 10-Q · filed 2015-04-01 | $23.20M derived: sum of 2 quarters · filed 2015-04-01 | $33.53M 10-Q · filed 2015-04-01 | $44.09M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-11-30 | $11.22M 10-Q · filed 2014-12-30 | $21.54M 10-Q · filed 2014-12-30 | $32.10M derived: sum of 3 quarters · filed 2015-07-30 | $42.63M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-08-31 | $10.32M 10-Q · filed 2014-09-30 | $20.88M derived: sum of 2 quarters · filed 2015-07-30 | $31.42M derived: sum of 3 quarters · filed 2015-07-30 | $41.36M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-05-31 | $10.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $21.09M derived: sum of 2 quarters · filed 2015-07-30 | $31.03M derived: sum of 3 quarters · filed 2015-07-30 | $40.79M 10-K · filed 2015-07-30 | ||||
| 2013-02-28 | $10.53M 10-Q · filed 2014-04-04 | $20.47M derived: sum of 2 quarters · filed 2014-04-04 | $30.23M 10-Q · filed 2014-04-04 | $39.60M derived: sum of 4 quarters · filed 2014-07-30 | ||||
| 2012-11-30 | $9.94M 10-Q · filed 2014-01-09 | $19.70M 10-Q · filed 2014-01-09 | $29.06M derived: sum of 3 quarters · filed 2014-07-30 | $37.99M derived: sum of 4 quarters · filed 2014-07-30 | ||||
| 2012-08-31 | $9.76M 10-Q · filed 2013-09-30 | $19.12M derived: sum of 2 quarters · filed 2014-07-30 | $28.05M derived: sum of 3 quarters · filed 2014-07-30 | $36.68M derived: sum of 4 quarters · filed 2014-07-30 | ||||
| 2012-05-31 | $9.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $18.29M derived: sum of 2 quarters · filed 2014-07-30 | $26.92M derived: sum of 3 quarters · filed 2014-07-30 | $35.03M 10-K · filed 2014-07-30 | ||||
| 2012-02-29 | $8.93M 10-Q · filed 2013-03-28 | $17.56M derived: sum of 2 quarters · filed 2013-03-28 | $25.66M 10-Q · filed 2013-03-28 | $33.62M derived: sum of 4 quarters · filed 2013-07-30 | ||||
| 2011-11-30 | $8.63M 10-Q · filed 2012-12-28 | $16.73M 10-Q · filed 2012-12-28 | $24.69M derived: sum of 3 quarters · filed 2013-07-30 | $31.74M derived: sum of 4 quarters · filed 2013-07-30 | ||||
| 2011-08-31 | $8.10M 10-Q · filed 2012-09-28 | $16.06M derived: sum of 2 quarters · filed 2013-07-30 | $23.11M derived: sum of 3 quarters · filed 2013-07-30 | $30.61M derived: sum of 4 quarters · filed 2013-07-30 | ||||
| 2011-05-31 | $7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $15.00M derived: sum of 2 quarters · filed 2013-07-30 | $22.51M derived: sum of 3 quarters · filed 2013-07-30 | $30.02M 10-K · filed 2013-07-30 | ||||
| 2011-02-28 | $7.04M 10-Q · filed 2012-03-30 | $14.55M derived: sum of 2 quarters · filed 2012-03-30 | $22.06M 10-Q · filed 2012-03-30 | |||||
| 2010-11-30 | $7.50M 10-Q · filed 2011-12-30 | $15.02M 10-Q · filed 2011-12-30 | ||||||
| 2010-08-31 | $7.51M 10-Q · filed 2011-09-30 | |||||||
| 2010-05-31 | $26.35M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |